SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,781.89 -251.89
( -0.34%)

Global Indices

Nasdaq

51,707.15 -164.40
(-0.32%)

Dow Jones

7,828.98 0.74
(0.01%)

Hang Seng

67,780.30 2.78
(0.00%)

Nikkei 225

10,730.66 80.33
(0.75%)

Forex

USD-INR

95.69 -0.76
(-0.79%)

EUR-INR

107.00 -1.04
(-0.96%)

GBP-INR

126.57 -1.05
(-0.82%)

JPY-INR

0.60 -0.01
(-0.89%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

37.16

96836.1

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.24

Back

CRISIL consolidated net profit rises 26.16% in the June 2026 quarter

Jul 22,2026

Net profit of CRISIL rose 26.16% to Rs 216.46 crore in the quarter ended June 2026 as against Rs 171.57 crore during the previous quarter ended June 2025. Sales rose 27.56% to Rs 1075.39 crore in the quarter ended June 2026 as against Rs 843.02 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1075.39	843.02	28
OPM %	28.63	28.32	-
PBDT	322.31	256.66	26
PBT	279.84	224.97	24
NP	216.46	171.57	26

72,781.89 -251.89 ( -0.34%)

51,707.15 -164.40 (-0.32%)

7,828.98 0.74 (0.01%)

67,780.30 2.78 (0.00%)

10,730.66 80.33 (0.75%)

95.69 -0.76 (-0.79%)

107.00 -1.04 (-0.96%)

126.57 -1.05 (-0.82%)

0.60 -0.01 (-0.89%)